国际医疗器械设计与制造技术展览会

Dedicated to design & manufacturing for medical device

September 24-26,2025 | SWEECC H1&H2

EN | 中文
   

The 9th IIMD China Summit-Implantable and Interventional Medical Device——New Technologies, New Applications, New Opportunities

Introduction

Agenda

Speaker

Sponsor/Package

Registration

Transportation

Advanced Active Medical Technologies

The 9th IIMD China Summit-Implantable and Interventional Medical Device——New Technologies, New Applications, New Opportunities

September 24th | Meeting Room C of Middle Hall, Shanghai World Expo Exhibition & Convention Center, Shanghai, China

Co-organizers:Medtec China

Background:

Background:

Under the dual drive of the “14th Five-Year Plan” for high-quality development of the medical equipment industry and the national Action Plan for Promoting Large-scale Equipment Renewal and Consumer Product Trade-in, China’s implantable and interventional medical device industry is undergoing historic changes. President Xi Jinping’s emphasis on “key core technology breakthroughs” and “self-reliance and controllability” strategies injects strong momentum into the industry, accelerating its transformation towards intelligent, precise, and domestically produced directions.

Currently, centralized procurement policies are reshaping the industry ecosystem, forcing companies to shift from “price competition” to “innovation breakthroughs,” significantly increasing the domestic substitution rate. Data shows that China’s medical equipment market reached 1.27 trillion yuan in 2023, with a compound annual growth rate of 14%. The domestic market share of high-end equipment has increased from less than 10% to over 40%.

Active implantable and interventional devices have become the main battlefield for innovation, with AI empowerment, biodegradable materials, energy ablation, and other cutting-edge technologies deeply integrated. Meanwhile, application scenarios continue to expand: ophthalmology, neurointervention, tumor intervention, and other fields are bursting with new vitality. However, the industry still faces challenges such as reliance on imported core components, insufficient primary healthcare capabilities, and the need to enhance participation in international standards. Therefore, this conference will focus on new trends and technologies, discussing paths for technological breakthroughs, clinical application transformations, and global market strategies to help companies seize growth opportunities.

Participants:

  • Implantable and interventional medical device manufacturers: heads of the departments of R&D, design, and technology, as well as project/company leaders.
  • Equipment suppliers and service providers
  • Clinicians, universities and research institutes
  • Other professionals interested in implantable and interventional medical devices

Agenda:

Time

Agenda

9:50-10:00

Moderator Remarks

10:00-10:30

The New Industrial Landscape Driven by Policy and Market Forces

10:30-11:00

Advances in Robotic Magnetic Navigation-Guided Atrial Fibrillation Ablation

11:00-11:30

echnological Breakthroughs in Cardiac Electrophysiology Under Localization Trends

11:30-12:00

Cardiac Magnetic Navigation System

12:00-13:20

Lunch & Exhibition

13:20-13:30

Moderator Remarks

13:30-14:00

Remote Operation Technology for Vascular Intervention Robots

14:00-14:30

  Material Design and Breakthroughs in Active Implantable Devices
 
  TekniPlex (Reserved)

  14:30-15:00

  Robot-Assisted Joint Replacement for Precision Prosthesis Implantation

15:00-15:30

Clinical Applications and Latest Advances in Brain-Computer Interface and Neuromodulation Technologies

15:30-16:00

 Ingestible Gastrointestinal Monitoring and Therapy

16:00-16:10

Conference Close

*The agenda may be subject to changes due to adjustment of confirmed speakers.

speakers

 

Sponsor/Package

Sponsor/Package

Registration

Click to Register

Transportation

Hotel Reservation

X